THE PRESENCE of tumour specific antigens in mammary carcinoma is now well documented. Intracutaneous injection of antigens derived from autologous and allogeneic mammary tumours produced specific delayed-type skin reactions in some breast cancer patients, while similarly prepared benign or normal mammary tissue gave no response (Hughes and Lytton, 1964; Stewart and Orizaga, 1 971; Alford, Hollinshead and Herberman, 1973) .
The leucocyte migration test of S0berg and Bendixen (1967) has proved the most useful in vitro technique for the demonstration of tumour-specific antigens in breast carcinoma (Andersen et al., 1970; Segall et al., 1972; Cochran et al., 1972 Cochran et al., , 1973 (Wolf, 1969) to give a sediment of cell ghosts (membranes). The protein concentration of these preparations was adjusted to 2 mg/ml and antigens were stored frozen in small aliquots until needed. For in vitro tests, the antigens were diluted in tissue culture medium 199 containing 10% foetal calf serum, NaHCO3 and antibiotics (199 + 10% FCS) to 50, 100, 150 and 200 ,ug/ml.
Seven days after operation, membranes and extract from each tumour were tested against autologous and allogeneic breast cancer patients' leucocytes and against cells from healthy volunteers. Follow-up tests of sensitivity to autologous antigen were performed 8-12 weeks after operation.
Leucocytes were separated from heparinized whole blood by sedimentation on FicollTriosil and were washed 3 times in 199 + 10% FCS. The method used for leucocyte migration was similar to that of Federlin et al. (1971) Twenty-seven of the patients have so far been re-tested at 2 months after operation. Four of the patients who were positive to autologous tumour at 7 days remained positive at follow-up; 11 were positive initially but appeared to have lost sensitivity by the time they were re-tested; and 10 were negative on both occasions. Two of the patients have become positive after giving an initially negative result. (1970); 8/13 (62%), Segall et al. (1972) and 6/8 (75%o), Cochran et al. (1972) .
Sixteen patients out of 30 tested (5300) showed sensitivity to allogeneic breast tumour antigens and in fact crossreactivity was observed in 7900 of patients positive to autologous antigens. The presence of cross-reacting antigens in breast carcinoma might indicate a viral influence in the aetiology of the disease (Sinkovics, 1970) and although this hypothesis remains to be substantiated, the possibility of using viral antigens rather than tissue-associated antigens might lead to further progress in the development of in vitro diagnostic and prognostic tests.
The selection of methods for preparation of tumour-specific antigens from malignant tisstlie is clearly of considerable importance. In our hands, tumour extracts (Andersen et al., 1970) inhibited migration in 8/34 cases, whereas further treatment of the extract to give a cell membrane preparation increased the number of positives to 12/34.
There appeared to be no significant difference between the results of leucocyte migration tests performed 7 days and 2 months after operation in 16 patients selected for regional radiotherapy and those of 11 patients receiving no postoperative treatment, but it is of interest to note that 8 of the 13 patients with histological evidence of axillary lymph node involvement were positive when tested 7 days after operation but had lost sensitivity by the 2 month test, whereas only 3/12 patients without metastases reacted in this way. The probability of there being a significant difference between these two groups of patients was 0 15 (X2 with Yates' correction).
The preliminary results presented here clearly await confirmation and extension. It is possible that serial follow-uV tests might provide useful prognostic information and the presence of common or crossreacting antigens in breast cancer might also indicate the usefulness of in vitro diagnostic tests for which pooled tumour membrane antigens might be employed.
